secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2026-07-21T20:05:53+00:00
Accession:  0001178913-26-003551
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silexion shareholders approve 10M share authorized increase and warrant exercisability
--------------------------------------------------------------------------------

- Meeting reconvened July 20, 2026 after July 13 adjournment due to lack of quorum.
- Proposal 1 (warrant exercisability) approved with 93.3% in favor (214,091 votes for, 15,293 against).
- Proposal 2 (authorized share increase) approved with 89.8% in favor (205,551 for, 23,382 against).
- Authorized shares increased from 5,900,000 to 15,900,000 ordinary shares (par value $0.135).
- Memorandum Amendment filed with Cayman Islands Registrar on July 21, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891326003551/0001178913-26-003551-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891326003551/zk2635714.htm
  HTML page:      https://secwatch.observer/filing/0001178913-26-003551

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer